Flagship Ventures Opportunities Fund I, L.P.'s Net Worth
-$134 Million
Who is Flagship Ventures Opportunities Fund I, L.P.?
Flagship Ventures Opportunities Fund I, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kaleido Biosciences, Inc., Foghorn Therapeutics Inc., Rubius Therapeutics, Inc., Axcella Health Inc., and Evelo Biosciences, Inc..
SEC CIK
Flagship Ventures Opportunities Fund I, L.P.'s CIK is 0001677345
Past Insider Trading and Trends
2019 was Flagship Ventures Opportunities Fund I, L.P.'s most active year for acquiring shares with 24 total transactions. Flagship Ventures Opportunities Fund I, L.P.'s most active month to acquire stocks was the month of April. 2019 was Flagship Ventures Opportunities Fund I, L.P.'s most active year for disposing of shares, totalling 20 transactions. Flagship Ventures Opportunities Fund I, L.P.'s most active month to dispose stocks was the month of April. 2022 saw Flagship Ventures Opportunities Fund I, L.P. paying a total of $69,099,363.15 for 44,100,390 shares, this is the most they've acquired in one year. In 2018 Flagship Ventures Opportunities Fund I, L.P. cashed out on 92,940,266 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.14% | 215K |
$11.50 | $2,472,500.00 | 5.41M |
Feb 8
| |||
Form 4
| +62.67% | 2M |
$7.50 | $15,000,000.00 | 5.19M |
Jun 4
| |||
Form 4
| +47.12% | 12M |
$15.00 | $13,999,995.00 | 37.48M |
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foghorn Therapeutics Inc. (FHTX) Snapshot price: $3.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.67M |
$16.00 |
—
| 12.67M |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.057
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.89% | 210K |
$29.00 | $6,090,000.00 | 23.89M |
Mar 19
| |||
Form 4
| +185.29% | 33.3M |
—
|
—
| 51.27M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axcella Health Inc. (AXLA) Snapshot price: $0.6664
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +79.47% | 10.38M |
$1.64 | $17,029,366.40 | 23.45M |
Oct 13
| |||
Form 4
| +72.21% | 6.32M |
$1.91 | $12,069,998.61 | 15.07M |
Mar 16
| |||
Form 4
| +76.74% | 3.8M |
$4.75 | $18,050,000.00 | 8.75M |
May 18
| |||
Form 4
| +46.30% | 6.03M |
$20.00 |
—
| 19.07M |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.0475
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +288.55% | 27.4M |
$1.46 | $39,999,998.14 | 36.89M |
May 27
| |||
Form 4
| +1.39% | 130K |
$15.00 | $1,950,000.00 | 9.49M |
Feb 2
| |||
Form 4
| +99.33% | 4.67M |
$3.75 | $17,499,997.50 | 9.36M |
Jun 29
| |||
Form 4
| +447.55% | 14.9M |
$16.00 | $4,500,000.00 | 18.23M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||